Impact of Advanced Crohn's Therapies on Sleep Quality
Official title: Impact of Advanced Crohn's Disease Therapies on Sleep Quality
Run by Tel-Aviv Sourasky Medical Center · NCT07649408 · Data updated 2026-11-12
In adults with Crohn's disease, this study tests whether starting advanced therapies changes sleep quality, using a Fitbit and sleep diaries to track patterns over about six months.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Tel-Aviv Sourasky Medical Center Government |
| Drugs / interventions | vedolizumab, Ustekinumab |
| Locations | 1 site (Tel Aviv) |
| Status | Recruiting |
| Started | August 6, 2025 |
| Main results expected | October 2027 |
| Study ends | December 2027 |
| Registry record updated | June 16, 2026 |
| Trial ID | NCT07649408 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with Crohn's disease starting advanced therapy and willing to wear a Fitbit and complete sleep assessments.
✕Probably not a fit
Patients who do not respond to therapy or who have sleep disorders unrelated to Crohn's disease may see little to no change in sleep quality.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study follows adults with Crohn's disease who are about to begin advanced therapy. Participants will wear a Fitbit to monitor sleep, keep a sleep diary, and complete a sleep quality questionnaire, with follow-up over 26 weeks to see how sleep relates to treatment response. The study aims to describe associations between disease improvement and changes in sleep patterns, rather than testing a specific intervention. Data on disease activity and treatment response will be collected to explore potential links with sleep quality. The research acknowledges the complex interplay between inflammation, sleep, and quality of life in IBD.
Why it matters
Potential benefit: If successful, findings could help clinicians understand how effective Crohn's therapies may improve sleep and overall well-being.
How similar studies have gone: Prior observational work suggests sleep can be affected by inflammatory activity, but trials directly linking Crohn's treatment response to sleep changes are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with established diagnosis of Crohn's Disease * Patients with active inflammation, defined as HBI score ≥ 5 and either CRP\>5 or stool calprotectin\>250 mcg/gr. * Patients starting advanced treatment as part of routine medical care (Anti TNFs, vedolizumab, Ustekinumab, IL-23 inhibitors, Jak inhibitors or S1P inhibitors). Exclusion Criteria: * Inability to give informed consent and complete the study protocol. * Pregnant or lactating women * Inability or reluctance to follow through with the study protocol, including (but not exclusive) to: questionnaires, wearing the watch while sleeping. * Patients diagnosed with UC or indeterminate IBD. * Other sleep disorders Obstructive sleep apnea overactive bladder insomnia shift work disorder restless leg syndrome Periodic limb movement of sleep Narcolepsy * Use of sleep medication - such as benzodiazepines or cannabis. * Recent abdominal surgery - previous 4 weeks. * Severe systemic disease - CVD, Kidney, liver - as jugged by physician's discretion. * Patients with ileostomy or short bowl syndrome.
Where it's running
-
Dep. of Gastroenterology, Tel Aviv Sourasky Medical Center
Tel Aviv, Israel Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Reduce ultra-processed foods to help kids with Crohn's stay in remission longer
This study tests whether and how reducing ultra-processed foods with dietitian guidance helps children and teens with Crohn's disease stay in remission longer.
-
Endoscopic stricturotomy vs balloon dilation for small bowel Crohn’s stricture
This trial tests whether endoscopic stricturotomy can be safely and effectively used to treat small bowel fibrotic strictures in Crohn’s disease, compared with endoscopic balloon dilation.
-
Prediction of postoperative recurrence in Crohn's disease after surgery
A multicenter study will test a multimodal model to predict which Crohn's patients are likely to have disease recur after intestinal resection.
-
Perianal fistula imaging comparison using TPUS, MRI, EUS, and EUA
This study tests how well four imaging methods—transperineal ultrasound, MRI, endoscopic ultrasound, and examination under anesthesia—detect and describe perianal fistulas in adults with Crohn's disease or unknown cause.
-
Familial IBD Early Risk
This study tests whether clinical, environmental, and immune factors in first-degree relatives of people with Crohn’s disease or ulcerative colitis can predict who will develop IBD.
-
Impact of sucralose on gut health in Crohn's disease
This study tests whether the non-nutritive sweetener sucralose changes gut bacteria in adults with Crohn's disease compared to healthy controls.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.